159 related articles for article (PubMed ID: 36333648)
1. Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [
Hooijman EL; Ntihabose CM; Reuvers TGA; Nonnekens J; Aalbersberg EA; van de Merbel JRJP; Huijmans JE; Koolen SLW; Hendrikx JJMA; de Blois E
EJNMMI Radiopharm Chem; 2022 Nov; 7(1):29. PubMed ID: 36333648
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of Analytical Methods for Radiochemical Purity of
Orhon P; Desruet MD; Piquemal M; De Leiris N; Djaileb L; Vuillez JP; Bedouch P; Leenhardt J
Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631349
[TBL] [Abstract][Full Text] [Related]
3. Improved quality control of [
Kraihammer M; Garnuszek P; Bauman A; Maurin M; Alejandre Lafont M; Haubner R; von Guggenberg E; Gabriel M; Decristoforo C
EJNMMI Radiopharm Chem; 2023 Mar; 8(1):7. PubMed ID: 36971890
[TBL] [Abstract][Full Text] [Related]
4. Radiochemical and analytical aspects of inter-institutional quality control measurements on radiopharmaceuticals.
de Blois E; de Zanger RMS; Chan HS; Konijnenberg M; Breeman WAP
EJNMMI Radiopharm Chem; 2019 Jan; 4(1):3. PubMed ID: 31659493
[TBL] [Abstract][Full Text] [Related]
5. Radiolysis-Associated Decrease in Radiochemical Purity of
Larenkov A; Mitrofanov I; Pavlenko E; Rakhimov M
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838872
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Multidose Preparation of a Ready-to-Use
Chakraborty A; Mitra A; Tawate M; Sahoo S; Lad S; Rakshit S; Gaikwad S; Basu S; Shimpi H; Banerjee S
Cancer Biother Radiopharm; 2021 Oct; 36(8):682-692. PubMed ID: 34402687
[No Abstract] [Full Text] [Related]
7. Production and Quality Control of [
Di Iorio V; Boschi S; Cuni C; Monti M; Severi S; Paganelli G; Masini C
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807385
[TBL] [Abstract][Full Text] [Related]
8. High-throughput radio-TLC analysis.
Wang J; Rios A; Lisova K; Slavik R; Chatziioannou AF; van Dam RM
Nucl Med Biol; 2020; 82-83():41-48. PubMed ID: 31891883
[TBL] [Abstract][Full Text] [Related]
9. Preparation of
Guleria M; Amirdhanayagam J; Sarma HD; Rallapeta RP; Krishnamohan VS; Nimmagadda A; Ravi P; Patri S; Kalawat T; Das T
Biomed Res Int; 2021; 2021():1555712. PubMed ID: 34845436
[TBL] [Abstract][Full Text] [Related]
10. A Specific HPLC Method to Determine Residual HEPES in [
Migliari S; Scarlattei M; Baldari G; Silva C; Ruffini L
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889351
[TBL] [Abstract][Full Text] [Related]
11. A rapid and systematic approach for the optimization of radio thin-layer chromatography resolution.
Laferriere-Holloway TS; Rios A; Lu Y; Okoro CC; van Dam RM
J Chromatogr A; 2023 Jan; 1687():463656. PubMed ID: 36463649
[TBL] [Abstract][Full Text] [Related]
12. Optimization of Labeling PSMA
Eppard E; Homann T; de la Fuente A; Essler M; Rösch F
J Nucl Med; 2017 Mar; 58(3):432-437. PubMed ID: 28082433
[TBL] [Abstract][Full Text] [Related]
13. Optimised quality control method for determination of the radiochemical purity of [
Pirot C; Peyronnet D; Vigne J
Eur J Hosp Pharm; 2024 Jun; 31(4):376-380. PubMed ID: 36690417
[TBL] [Abstract][Full Text] [Related]
14. Stability Matters: Radiochemical Stability of Therapeutic Radiopharmaceutical
Vyas M; Lim R; Fagan J; Chandrashekar R
J Nucl Med Technol; 2022 Sep; 50(3):244-247. PubMed ID: 35701217
[TBL] [Abstract][Full Text] [Related]
15. Validation of HPLC and TLC analytical methods to determine radiochemical purity of
Mutin J; Orhon P; Choisnard L; Lassiaz M; Bacot S; Ahmadi M; De Leiris N; Djaileb L; Broisat A; Ghezzi C; Bedouch P; Brunet MD; Leenhardt J
J Pharm Biomed Anal; 2024 Aug; 246():116224. PubMed ID: 38759321
[TBL] [Abstract][Full Text] [Related]
16. Radiolabeling of PSMA-617 with
Imura R; Ozeki AN; Shida N; Kobayashi M; Ida H; Wada Y; Akimitsu N; Kumakura Y
Nucl Med Biol; 2022; 106-107():21-28. PubMed ID: 34998216
[TBL] [Abstract][Full Text] [Related]
17. Development of a high-performance liquid chromatography method for rapid radiochemical purity measurement of [
Ioppolo JA; Alvarez de Eulate E; Cullen DR; Mohamed S; Morandeau L
J Labelled Comp Radiopharm; 2023 Mar; 66(3):58-72. PubMed ID: 36649714
[TBL] [Abstract][Full Text] [Related]
18. Bulk Scale Formulation of Therapeutic Doses of Clinical Grade Ready-to-Use
Mathur A; Prashant V; Sakhare N; Chakraborty S; Vimalnath KV; Mohan RK; Arjun C; Karkhanis B; Seshan R; Basu S; Korde A; Banerjee S; Dash A; Sachdev SS
Cancer Biother Radiopharm; 2017 Sep; 32(7):266-273. PubMed ID: 28910148
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of quenchers to reduce radiolysis of (111)In- or (177)Lu-labelled methionine-containing regulatory peptides. Maintaining radiochemical purity as measured by HPLC.
de Blois E; Chan HS; Konijnenberg M; de Zanger R; Breeman WA
Curr Top Med Chem; 2012; 12(23):2677-85. PubMed ID: 23339763
[TBL] [Abstract][Full Text] [Related]
20. Development and application of a fully automatic multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis.
Cui FB; Lv X; Yan CL; Eng WS; Yu SY; Zheng QH
Ann Nucl Med; 2024 Apr; 38(4):247-263. PubMed ID: 38145430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
